Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

13-06-2013 | Head and neck cancers | Article

Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer

Journal: Cancers of the Head & Neck

Authors: Henry S. Park, Roy H. Decker

Publisher: BioMed Central

Login to get access

Abstract

Background

Though treatments for head and neck cancer have improved in recent years, significant variation persists in the delivery of surgery, radiation therapy, and systemic therapy to patients throughout the United States.

Body

In this review, we explore the current evidence regarding radiation therapy utilization inequities across the spectra of race, socioeconomic status, and age. We also discuss hypothesized mechanisms for how non-clinical factors may influence shared clinical decisions between patients and providers. Finally, we suggest future directions for research in treatment disparities.

Conclusions

Radiation therapy continues to be delivered inequitably among certain subpopulations with head and neck cancer and other cancers. More research into the drivers of these disparities and interventions designed to address them are necessary.
Literature
1.
Mahal BA, Inverso G, Aizer AA, et al. Impact of African-American race on presentation, treatment, and survival of head and neck cancer. Oral Oncol. 2014;50:1177–81.CrossRefPubMed
2.
Subramanian S, Chen A. Treatment patterns and survival among low-income medicaid patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139:489–95.CrossRefPubMed
3.
Inverso G, Mahal BA, Aizer AA, et al. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes. J Oral Maxillofac Surg. 2016; Epub ahead of print. doi:10.​1016/​j.​joms.​2015.​12.​023.
4.
Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112 Suppl 1:S92–107.CrossRefPubMed
5.
McLaughlin JM, Anderson RT, Ferketich AK, et al. Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol. 2012;30:4493–500.CrossRefPubMedPubMedCentral
6.
Murphy CT, Galloway TJ, Handorf EA, et al. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. J Clin Oncol. 2016;34:169–78.CrossRefPubMed
7.
Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873–9.CrossRefPubMed
8.
Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12:127–36.CrossRefPubMedPubMedCentral
9.
Romesser PB, Cahlon O, Scher E, et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118:286–92.CrossRefPubMed
10.
Beadle BM, Liao KP, Elting LS, et al. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis. Cancer. 2014;120:702–10.CrossRefPubMed
11.
Sher DJ, Neville BA, Chen AB, et al. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis. Int J Radiat Oncol Biol Phys. 2011;81:e197–206.CrossRefPubMed
12.
Yu JB, Soulos PR, Sharma R, et al. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;83:e101–7.CrossRefPubMed
13.
Boero IJ, Paravati AJ, Xu B, et al. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy. J Clin Oncol. 2016;34:684–90.CrossRefPubMed
14.
Wuthrick EJ, Zhang Q, Machtay M, et al. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015;33:156–64.CrossRefPubMedPubMedCentral
15.
Chen AB, D'Amico AV, Neville BA, et al. Provider case volume and outcomes following prostate brachytherapy. J Urol. 2009;181:113–8. discussion 118.CrossRefPubMed
16.
Chen YW, Mahal BA, Muralidhar V, et al. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016;94:683–90.CrossRefPubMed
17.
Wang EH, Rutter CE, Corso CD, et al. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol. 2015;10:937–43.CrossRefPubMed
18.
Lin JF, Berger JL, Krivak TC, et al. Impact of facility volume on therapy and survival for locally advanced cervical cancer. Gynecol Oncol. 2014;132:416–22.CrossRefPubMed
19.
McGinley KF, Tay KJ, Moul JW. Prostate cancer in men of African origin. Nat Rev Urol. 2016;13:99–107.CrossRefPubMed
20.
Mahal BA, Aizer AA, Ziehr DR, et al. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology. 2014;84:386–92.CrossRefPubMed
21.
Chao GF, Krishna N, Aizer AA, et al. Asian Americans and prostate cancer: A nationwide population-based analysis. Urol Oncol. 2016;34:233.e7–233.e15.
22.
Moses KA, Paciorek AT, Penson DF, et al. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010;28:1069–74.CrossRefPubMedPubMedCentral
23.
Bledsoe TJ, Park HS, Rutter CE, et al. Minimally invasive surgery and external beam radiation therapy selection for prostate cancer varies significantly by health insurance status. Int J Radiat Oncol Biol Phys. 2015;93:e358–59.
24.
Mahal BA, Chen YW, Efstathiou JA, et al. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study. Cancer. 2016;122:1505–12.
25.
Grant SR, Walker GV, Koshy M, et al. Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy. Int J Radiat Oncol Biol Phys. 2015;93:968–75.CrossRefPubMed
26.
Morris AM, Billingsley KG, Baxter NN, et al. Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg. 2004;139:151–5. discussion 156.CrossRefPubMed
27.
Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643–50.CrossRefPubMed
28.
August DA, Rea T, Sondak VK. Age-related differences in breast cancer treatment. Ann Surg Oncol. 1994;1:45–52.CrossRefPubMed
29.
Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat. 1996;40:65–74.CrossRefPubMed
30.
Goulart BH, Reyes CM, Fedorenko CR, et al. Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer. J Oncol Pract. 2013;9:42–50.CrossRefPubMedPubMedCentral
31.
Vinod SK, Simonella L, Goldsbury D, et al. Underutilization of radiotherapy for lung cancer in New South Wales, Australia. Cancer. 2010;116:686–94.CrossRefPubMed
32.
Freeman HP, Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am. 2005;14:655–69.CrossRefPubMed
33.
Gerend MA, Pai M. Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomarkers Prev. 2008;17:2913–23.CrossRefPubMed
34.
Kagawa-Singer M, Dadia AV, Yu MC, et al. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin. 2010;60:12–39.CrossRefPubMed
35.
Lannin DR, Mathews HF, Mitchell J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279:1801–7.CrossRefPubMed
36.
Lannin DR, Mathews HF, Mitchell J, et al. Impacting cultural attitudes in African-American women to decrease breast cancer mortality. Am J Surg. 2002;184:418–23.CrossRefPubMed
37.
Phillips JM, Cohen MZ, Tarzian AJ. African American women's experiences with breast cancer screening. J Nurs Scholarsh. 2001;33:135–40.CrossRefPubMed
38.
Johnson KS, Elbert-Avila KI, Tulsky JA. The influence of spiritual beliefs and practices on the treatment preferences of African Americans: a review of the literature. J Am Geriatr Soc. 2005;53:711–9.CrossRefPubMed
39.
George M, Margolis ML. Race and lung cancer surgery--a qualitative analysis of relevant beliefs and management preferences. Oncol Nurs Forum. 2010;37:740–8.CrossRefPubMed
40.
van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med. 2000;50:813–28.CrossRefPubMed
41.
Vernon SW, Vogel VG, Halabi S, et al. Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res Treat. 1993;28:137–44.CrossRefPubMed
42.
Mandelblatt JS, Edge SB, Meropol NJ, et al. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J Clin Oncol. 2003;21:855–63.CrossRefPubMed
43.
Taylor TR, Williams CD, Makambi KH, et al. Racial discrimination and breast cancer incidence in US Black women: the Black Women's Health Study. Am J Epidemiol. 2007;166:46–54.CrossRefPubMed